# CytoTronics, Inc. — Form D

CytoTronics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-11. The offering totals $13.5M, of which $13.5M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2024-10-11
- Form: D
- Accession: 0002036555-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $13.5M
- Amount sold: $13.5M
- Investors: 10
- Date of first sale: 2024-03-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-526547

## Issuer

- Name: CytoTronics, Inc.
- CIK: 0002036555
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 38 Wareham Street, Boston, MA, 02118
- Phone: 714-671-9704

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| JEFFREY ABBOTT | Director | San Francisco, CA |
| Jenna Abelli | Director | Boston, MA |
| Douglas Kahn | Director | Boston, MA |
| SAMEER ROHATGI | Director | CLEVELAND, OH |
| Wenxuan Wu | Director | Boston, MA |
| JEFFREY ABBOTT | Executive Officer | San Francisco, CA |
| Wenxuan Wu | Executive Officer | Boston, MA |

## More

- [CIK 2036555 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2036555&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002036555-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.